TABLE 1.
Clinical and Pathologic Patient Characteristics for Dose Level 1 and Dose Level 2
| Characteristics | No. of Patients (%) | ||
|---|---|---|---|
| DL1, n = 7 | DL 2, n = 6 | Overall, n = 13 | |
| Age: Median [range], Years | 50 [27‐57] | 50.5 [43‐65] | 50 [28‐65] |
| Race | |||
| Black | 3 (42.9) | 4 (66.7) | 7 (53.8) |
| Non‐Hispanic | 3 (42.9) | 3 (50.0) | 6 (46.2) |
| Hispanic | — | 1 (16.7) | 1 (7.7) |
| White | 4 (57.1) | 2 (33.3) | 6 (46.2) |
| Non‐Hispanic | — | 2 (33.3) | 2 (15.4) |
| Hispanic | 4 (57.1) | — | 4 (30.7) |
| Histology | |||
| Squamous cell | 7 (100.0) | 6 (100.0) | 13 (100.0) |
| Adenocarcinoma | — | — | — |
| Stage, FIGO 2009 | |||
| IIA | — | 1 (16.7) | 1 (7.7) |
| IIB | 7 (100.0) | 2 (33.3) | 9 (69.2) |
| IIIA | — | — | — |
| IIIB | — | 2 (33.3) | 2 (15.3) |
| IVA | — | 1 (16.7) | 1 (7.7) |
| Positive pelvic lymph nodes on CT/PET‐CT | 4 (57.1) | 3 (50.0) | 7 (53.8) |
Abbreviations: CT, computed tomography; DL1, dose level 1; DL2, dose level 2; FIGO, International Federation of Gynecology and Obstetrics; PET, positron emission tomography.